Application of immune repertoire sequencing in cancer immunotherapy
- 1 September 2019
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 74, 105688
Abstract
No abstract availableKeywords
Funding Information
- Health and Family Planning Commission of Gansu (2018-QN-13)
This publication has 118 references indexed in Scilit:
- Genetic measurement of memory B-cell recall using antibody repertoire sequencingProceedings of the National Academy of Sciences, 2013
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid LeukemiaNew England Journal of Medicine, 2013
- High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessmentProceedings of the National Academy of Sciences, 2011
- Adoptive Transfer of Tumor Reactive B Cells Confers Host T-Cell Immunity and Tumor RegressionClinical Cancer Research, 2011
- Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypesGenome Research, 2011
- CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potentialClinical and Experimental Immunology, 2008
- Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloningJournal of Immunological Methods, 2008
- Prognostic Factors Related to Clinical Response in Patients with Metastatic Melanoma Treated by CTL-Associated Antigen-4 BlockadeClinical Cancer Research, 2007
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- Mutations of the BRAF gene in human cancerNature, 2002